Numerous US states have passed laws mandating expanded insurance coverage for biomarker tests. However, commercial insurers are confused with how to adapt their policies to these new regulations. With very little information and guidance, payors need a clear understanding and action plan for the states they cover and for the variety of patient populations they serve.
A one-size fits all approach won’t work. Whether your plan operates in states that have yet to enact legislation or in those where law has been passed, there are actions for you to take to ensure that members receive the proper genetic test, to identify the right care, at the correct cost.
Join InformedDNA on Wednesday, May 22 for a genomic expert-led webinar where we’ll unravel the intricacies of the new biomarker legislation and provide practical guidance and tools to help your plan prepare to implement the changes to comply with the law.
Register today to:
- Gain clear guidance, through specific examples, on how to navigate variability in legislative definitions and apply professional society guideline hierarchies (like NCCN, FDA, CMS).
- Understand specific utilization cost implications for commercial and Medicaid plans, highlighting potential increases in per member per month costs (PMPM) and issues with “stacked” coding practices.
- Gain strategies on how to operationalize coverage to align with clinical aspects of mandates, managing increased utilization without overwhelming costs.
Free Tool
All attendees will receive a complimentary checklist of essential questions for compliance and case processing teams, aiding in immediate application of learned strategies.
Biomarker legislation is still in its infancy, promising continual changes and evolution. Don’t navigate this murky terrain alone—join us and gain access to expert-level insights to stay ahead of the curve and keep your health plan compliant.
